Merit Financial Group’s Abivax ABVX Stock Holding History
Bought
Maintained
Sold
Other funds holding ABVX
DGM
Merit Financial Group's ABVX Position: Q3 2026 in Review
Merit Financial Group increased its Abivax (ABVX) stake by 46% in Q3 2026, buying an estimated $125K and bringing the position to 3,288 shares worth $326K. The position accounts for ﹤0.01% of the portfolio, ranked #1857.
Merit Financial Group first reported a position in ABVX in Q4 2025 and has held it in 4 quarters since. 319 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.
- Merit Financial Group held 3,288 shares of Abivax worth $326K as of Q3 2026.
- Merit Financial Group bought 1,033 Abivax shares in Q3 2026, an estimated $125K.
- Abivax made up ﹤0.01% of Merit Financial Group's portfolio in Q3 2026, its #1857 holding.
- Merit Financial Group first reported a position in Abivax in Q4 2025 and has held it in 4 quarters since.
- 319 funds tracked by Wall St. Rank held Abivax as of Q3 2026.
Based on Merit Financial Group's 13F filing for Q3 2026, filed 6 Nov 2026.